Each uncoated tablet contains Atenolol I.P. 50mg and Indapamide I.P. 2.5mg
Oral Tablets
Anti hypertensive and anti anginal
As directed by physician
Should not use if allergic to atenolol or indapamide or any of the other ingredients in the product. Atelol-D is contraindicated in sinus bradycardia, sinus node dysfunction, heart block > 1st degree, compensated cardiac failure, cardiogenic shock, bronchospastic diseases, peripheral vascular diseases, anuria, severe hepatic impairment. Also contraindicated during pregnancy .
While generally safe for use, but in case of compensated heart failure. variant angina, acute MI, DM; peripheral vascular disorders; hepatic and renal dysfunction; elderly patients, children, pregnancy, lactation, fluid or electrolyte imbalance, hyperuricaemia, and lupus erythematosus.
Decreased effect with aluminum and calcium salts, barbiturates, cholestyramine, NSAIDs, ampicillin,rifampicin. Additive effect with other antihypertensive agents and diuretics. Increased chance of hypokalaemia with corticosteroids, corticotropin and amphotericin. Potentially Fatal: Increased risk of lithium toxicity. Hypokalaemia enhances digitalis toxicity with cardiac gycosides.
Category D.
Drowsiness, dizziness, light-headedness, blurred vision, coldness of the hands and feet, tired muscles, slowed heartbeats, sleep disturbances, dry mouth, nausea and vomiting, diarrhoea, constipation and abdominal cramps, skin rashes and/or dry eyes, weakness, fatigue, agitation, nervousness, anorexia, orthostatic hypotension, palpitations, hypokalaemia, hyponatraemia, and metabolic alkalosis.
According to toxixity studies, the most important signs to be expected following acute overdose of Atelol-D are lethargy, sinus pause, bradycardia, hypotension, bronchospasm, hypoglycaemia, nausea, vomiting, weakness, GI disorders, and electrolyte imbalance.
